News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,680 Results
Type
Article (14196)
Company Profile (282)
Press Release (252202)
Section
Business (79501)
Career Advice (153)
Deals (13224)
Drug Delivery (35)
Drug Development (50443)
Employer Resources (31)
FDA (5715)
Job Trends (5127)
News (144382)
Policy (10028)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21636)
ALS (61)
Alzheimer's disease (833)
Antibody-drug conjugate (ADC) (87)
Approvals (5731)
Artificial intelligence (109)
Autoimmune disease (13)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (19)
Breast cancer (142)
Cancer (1310)
Cardiovascular disease (112)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (307)
Cervical cancer (8)
Clinical research (40905)
Collaboration (499)
Compensation (221)
Complete response letters (13)
COVID-19 (1034)
CRISPR (37)
C-suite (146)
Cystic fibrosis (76)
Data (1371)
Denatured (11)
Depression (29)
Diabetes (126)
Diagnostics (1293)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (78)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (82)
Earnings (29683)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48163)
Executive appointments (408)
FDA (6340)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (467)
Gene editing (89)
Generative AI (9)
Gene therapy (232)
GLP-1 (358)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6590)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (80)
Indications (18)
Infectious disease (1096)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (58)
Interviews (17)
IPO (7261)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (203)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (186)
Lymphoma (84)
Machine learning (1)
Management (7)
Manufacturing (116)
MASH (49)
Medical device (2588)
Medtech (2589)
Mergers & acquisitions (6255)
Metabolic disorders (366)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (60)
Neuropsychiatric disorders (23)
Neuroscience (1206)
NextGen: Class of 2025 (2017)
Non-profit (852)
Northern California (1559)
Now hiring (21)
Obesity (186)
Opinion (100)
Ovarian cancer (60)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (107)
Partnered (8)
Patents (111)
Patient recruitment (66)
Peanut (35)
People (25515)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14441)
Phase II (19033)
Phase III (12035)
Pipeline (735)
Podcasts (47)
Policy (38)
Postmarket research (852)
Preclinical (6064)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (275)
Real estate (1414)
Recruiting (12)
Regulatory (8569)
Reports (15)
Research institute (937)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (91)
Series B (60)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1386)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (35)
United States (12206)
Vaccines (205)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (84)
Last 7 days (450)
Last 30 days (1675)
Last 365 days (20023)
2025 (4858)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17223)
Australia (2919)
California (3545)
Canada (1055)
China (325)
Colorado (138)
Connecticut (143)
Delaware (88)
Europe (37037)
Florida (417)
Georgia (109)
Idaho (16)
Illinois (213)
India (8)
Indiana (85)
Iowa (1)
Japan (71)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (444)
Massachusetts (2802)
Michigan (69)
Minnesota (137)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (889)
New Mexico (12)
New York (965)
North Carolina (523)
North Dakota (4)
Northern California (1559)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (678)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1386)
Tennessee (25)
Texas (410)
Utah (48)
Virginia (70)
Washington D.C. (28)
Washington State (321)
Wisconsin (13)
266,680 Results for "cygnal therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Cygnal Therapeutics to Present Poster at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology , will present a poster this week at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting . The conference will be held online as a virtual event. Cygnal’s poster will discuss research on t
November 9, 2020
·
1 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Genetown
Cygnal Therapeutics to Present at the 2020 Stifel Virtual Healthcare Conference
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, today announced that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview at the 2020 Stifel Virtual Healthcare Conference on Tuesday, November 17, 2020 at 8:40 a.m. E.T.
November 13, 2020
·
1 min read
Genetown
Cygnal Therapeutics to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2021
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, will present two posters at the American Association for Cancer Research (AACR) Annual Meeting 2021, which will take place virtually from April 10-15 and May 17-21, 2021.
March 19, 2021
·
1 min read
Genetown
Cygnal Therapeutics Named to Chemical & Engineering News’ 10 Start-Ups to Watch List
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, announced that it has been named as one of Chemical & Engineering News’ 10 Start-Ups to Watch in 2020.
November 16, 2020
·
2 min read
Business
Cygnal Therapeutics Announces Scientific Advisory Board
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology, today announced the company’s Scientific Advisory Board (SAB).
January 31, 2020
·
8 min read
Genetown
Cygnal Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology , today announced that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview at the Piper Sandler 32nd Annual Virtual Healthcare Conference. The presentation will be available fo
November 23, 2020
·
1 min read
Genetown
Cygnal Therapeutics to Present at the 2020 Wells Fargo Virtual Healthcare Conference
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology , today announced that Pearl Huang, Ph.D., President and Chief Executive Officer, will present a company overview as part of Wells Fargo’s 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 3:
September 4, 2020
·
1 min read
Business
Flagship Pioneering Unveils Cygnal Therapeutics
Company is Developing Drugs in the Field of Exoneural Biology to Address Cancer, Inflammatory Disease, and More [08-October-2019] CAMBRIDGE, Mass. , Oct. 8, 2019 /PRNewswire/ -- Flagship Pioneering, a unique life sciences innovation enterprise, today unveiled Cygnal Therapeutics . Founded in 2017 in Flagship Labs, Flagship’s innovation foundry, Cygnal is the first co
October 8, 2019
·
5 min read
Business
Cygnal Therapeutics Expands Leadership Team with Appointment of John A. Wagner, M.D., Ph.D., as Chief Medical Officer
Cygnal Therapeutics, the first company to build a platform to develop drugs in the new field of exoneural biology , announced today that John A. Wagner , M.D., Ph.D., has joined the company as chief medical officer (CMO). Since unveiling in 2019 , Cygnal has deepened its executive and scientific leadership. Dr. Wagner is th
September 16, 2020
·
3 min read
1 of 26,668
Next